Hawaii HIV Immunology and Vaccine Core
Hawaii HIV Immunology and Vaccine Core
批准号:
6719824
负责人:
EDWIN C CADMAN
金额:
$64.1万
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-09-01 至 2006-07-31
中文摘要
描述(由申请人提供):夏威夷大学马诺亚分校(UHM)的RCMI项目是太平洋盆地内主要的高等教育机构,其学生主要由亚洲人和太平洋岛民组成,已经开始了新千年生物医学和健康领域卓越研究的“复兴”。机构基金正在利用RCMI的资金加速分子药理学、免疫遗传疾病和hiv相关疾病病理生物学方面的卓越研究发展。此外,核心支持活动正在扩大,包括一个加强的分子生物学核心设施,用于快速出现的技术;通过扩大计算机网络支援设施,使计算机网络能力得到更充分的发展;以及新成立的生物统计学和数据管理基金,以提供急需的生物统计学支持。目前关于RCMI补充资金的提议将利用以前由RCMI资金支持的艾滋病毒临床试验能力和人类逆转录病毒学和分子流行病学方面的现有优势,建立细胞和分子免疫学以及艾滋病毒疫苗试验能力方面急需的能力。已为拟议的艾滋病毒免疫学和疫苗核心征聘了强有力的领导和专家顾问,并已确定了一个直接的用户群。通过RCMI的支持开发的增强的专门知识将使人们能够充分和积极地参与艾滋病临床试验小组进行的具有免疫学终点的研究,以及通过艾滋病毒疫苗试验网络进行的未来艾滋病毒疫苗和免疫疗法的临床试验。此外,这种新发现的能力将加强正在进行的关于艾滋病毒相关痴呆的研究项目和其他纵向队列研究,特别是在感染艾滋病毒的老年人中。这一举措解决了地方和区域的需要,并符合该机构和夏威夷州的总体目标,即成为艾滋病毒/艾滋病研究、培训、治疗和预防的区域卓越中心。
英文摘要
DESCRIPTION (provided by applicant): The RCMI Program at the University of Hawaii at Manoa (UHM), the principal institution of higher learning within the Pacific Basin whose student body is comprised predominantly of Asians and Pacific Islanders, has begun a "renaissance" of research excellence in biomedicine and health for the new millennium. RCMI funds are being leveraged by institutional funds to accelerate the development of research excellence in molecular pharmacology, immunogenetic disorders, and pathobiology of HIV-associated disorders. In addition, the Core Support activity is being expanded to include a strengthened Molecular Biology Core Facility for rapidly emerging technologies; a more fully developed computer network capacity through an expanded Computer Network Support Facility; and a newly created Biostatistics and Data Management Facility for much-needed biostatistical support. The current proposal for RCMI supplemental funds will build on existing strengths in HIV clinical trials capacity and expertise in human retrovirology and molecular epidemiology, previously supported by RCMI funds, to build much-needed capacity in cellular and molecular immunology and in HIV vaccine trials capability. Strong leadership has been recruited and expert consultants have been enlisted for the proposed HIV Immunology and Vaccine Core, and an immediate user base has been identified. The enhanced expertise developed through RCMI support will allow full and active participation in studies with immunological endpoints conducted by the AIDS Clinical Trials Group (ACTG) and in clinical trials of future HIV vaccines and immune-based therapies, conducted through the HIV Vaccine Trials Network. Moreover, this newfound capacity will enhance ongoing research projects on HIV-associated dementia and other longitudinal cohort studies, particularly among elderly individuals infected with HIV. This initiative addresses local and regional needs and is consistent with the overall goals of the institution and the State of Hawaii to become a regional center of excellence for research, training, treatment and prevention of HIV/AIDS.
SECTION 2 - HAWAII HIV IMMUNOLOGY AND VACCINE CORE
Ethnic minority populations in the United States have been disproportionately affected by HIV/AIDS. As such, it is imperative that minority-serving institutions play a lead role in developing effective prevention research programs for HIV. While considerable infrastructure has been built in HIV clinical trials expertise and in molecular retrovirology at the University of Hawaii at Manoa (UHM), an area of comparative weakness has been in HIV immunology and vaccine research. The long-term goal of the Hawaii AIDS Research Program at UHM is to establish a truly comprehensive center of excellence for research and training in HIV/AIDS and treatment and prevention of HIV infection. The objective of this proposal for supplemental RCMI funds is to build on existing strengths in human retrovirology and AIDS clinical trials to develop much-needed capacity in cellular and molecular immunology and HIV vaccine research.
Specific Aim 1. Expand laboratory capabilities in cellular and molecular immunology to allow greater participation in ACTG trials, to expand the scope of currently funded HIV research and to serve as the HIV immunology reference laboratory for the Joint Asia Pacific HIV/AIDS Prevention Program.
Specific Aim 2. Build institutional capacity in HIV vaccine trials research to gain entry into the HIV Vaccine Trials Network (HVTN).
Specific Aim 3. Develop strong national and international collaborations with other institutions, lead agencies and companies involved in the testing of novel immune therapeutics and preventive HIV vaccines.
Our expectations at the end of the grant period are that UHM will be a major reference center for immunological tests as they relate to the evaluation of HIV vaccine efficacy. Moreover, we expect UHM to become a designated site of the nationwide HVTN. These developments will have a significant impact on the continued development of the Hawaii AIDS Research Program and on establishing a regional reference center for HIV vaccine trials, particularly those conducted in Asia, where new cases of HIV/AIDS will far exceed those in Africa during this millennium.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
SELECTIVE RESEARCH EXCELLENCE IN BIOMEDICINE & HEALTH: ADMIN
-
批准号:7011438
-
项目类别:
-
资助金额:$27.33万
-
财政年份:2004
-
负责人:EDWIN C CADMAN
-
依托单位:
JABSOM Endowed Chair for Native Hawaiian Health
-
批准号:6601031
-
项目类别:
-
资助金额:$156.25万
-
财政年份:2002
-
负责人:EDWIN C CADMAN
-
依托单位:
JABSOM Endowed Chair for Native Hawaiian Health
-
批准号:6663769
-
项目类别:
-
资助金额:$156.25万
-
财政年份:2002
-
负责人:EDWIN C CADMAN
-
依托单位:
HAWAII MINORITY RESEARCH INFRASTRUCTURE SUPPORT PROGRAM
-
批准号:6528305
-
项目类别:
-
资助金额:$32.98万
-
财政年份:2001
-
负责人:EDWIN C CADMAN
-
依托单位:
HAWAII MINORITY RESEARCH INFRASTRUCTURE SUPPORT PROGRAM
-
批准号:6616232
-
项目类别:
-
资助金额:$27.43万
-
财政年份:2001
-
负责人:EDWIN C CADMAN
-
依托单位:
HAWAII MINORITY RESEARCH INFRASTRUCTURE SUPPORT PROGRAM
-
批准号:6416673
-
项目类别:
-
资助金额:$33.27万
-
财政年份:2001
-
负责人:EDWIN C CADMAN
-
依托单位:
RCMI CLINICAL RESEARCH INFRASTRUCTURE INITIATIVE
-
批准号:6646552
-
项目类别:
-
资助金额:$141.58万
-
财政年份:1995
-
负责人:EDWIN C CADMAN
-
依托单位:
RCMI CLINICAL RESEARCH INFRASTRUCTURE INITIATIVE
-
批准号:6394642
-
项目类别:
-
资助金额:$163.17万
-
财政年份:1995
-
负责人:EDWIN C CADMAN
-
依托单位:
RCMI CLINICAL RESEARCH INFRASTRUCTURE INITIATIVE
-
批准号:6529819
-
项目类别:
-
资助金额:$183.95万
-
财政年份:1995
-
负责人:EDWIN C CADMAN
-
依托单位:
EFFECTS OF FLUOROPYRIMIDINE ON RNA STRUCTURE & FUNCTION
-
批准号:3174295
-
项目类别:
-
资助金额:$4.54万
-
财政年份:1987
-
负责人:EDWIN C CADMAN
-
依托单位:
EFFECTS OF FLUOROPYRIMIDINE ON RNA STRUCTURE & FUNCTION
-
批准号:3174294
-
项目类别:
-
资助金额:$17.16万
-
财政年份:1987
-
负责人:EDWIN C CADMAN
-
依托单位:
EFFECTS OF FLUOROPYRIMIDINE ON RNA STRUCTURE & FUNCTION
-
批准号:3174293
-
项目类别:
-
资助金额:$17.26万
-
财政年份:1987
-
负责人:EDWIN C CADMAN
-
依托单位:
IMPROVING ANIMAL RESOURCES
-
批准号:6588687
-
项目类别:
-
资助金额:$68.17万
-
财政年份:1986
-
负责人:EDWIN C CADMAN
-
依托单位:
Selective Research Excellence in Biomedicine and Health
-
批准号:6665130
-
项目类别:
-
资助金额:$288.58万
-
财政年份:1986
-
负责人:EDWIN C CADMAN
-
依托单位:
Selective Research Excellence in Biomedicine and Health
-
批准号:6529990
-
项目类别:
-
资助金额:$282.1万
-
财政年份:1986
-
负责人:EDWIN C CADMAN
-
依托单位:
Selective Research Excellence in Biomedicine and Health
-
批准号:6368126
-
项目类别:
-
资助金额:$203.52万
-
财政年份:1986
-
负责人:EDWIN C CADMAN
-
依托单位:
FLUOROPYRIMIDINES ON RNA STRUCTURE AND FUNCTION
-
批准号:3174290
-
项目类别:
-
资助金额:$3.32万
-
财政年份:1984
-
负责人:EDWIN C CADMAN
-
依托单位:
EFFECTS OF FLUOROPYRIMIDINIES ON RNA STRUCTURE AND FUNCT
-
批准号:3174289
-
项目类别:
-
资助金额:$1.96万
-
财政年份:1984
-
负责人:EDWIN C CADMAN
-
依托单位:
FLUOROPYRIMIDINES ON RNA STRUCTURE AND FUNCTION
-
批准号:3174291
-
项目类别:
-
资助金额:$10.62万
-
财政年份:1984
-
负责人:EDWIN C CADMAN
-
依托单位:
FLUOROPYRIMIDINES ON RNA STRUCTURE AND FUNCTION
-
批准号:3174292
-
项目类别:
-
资助金额:$10.86万
-
财政年份:1984
-
负责人:EDWIN C CADMAN
-
依托单位:
国内基金
海外基金
登录
查看更多内容
人类免疫缺陷病毒(HIV)总核酸检测试剂盒
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:尹富君
-
依托单位:
基于深度测序与SNV 芯片的HIV重复感染与毒株重组机制研究
-
批准号:2026JJ81281
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:徐艳
-
依托单位:
HIV相关肺癌免疫微环境中关键免疫细胞亚群的功能特征与调控机制研究
-
批准号:2026JJ81995
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:田中秋
-
依托单位:
PGT123中和抗体修饰的工程化载肽囊泡疫苗通过诱导CD4+ T细胞极化在抗HIV感染中的应用和机制研究
-
批准号:JCZRQNB202600778
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
HIV相关血管早衰的免疫炎症机制及基于循环生物标志物的风险评估模型构建
-
批准号:2026JJ80647
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:关艳丽
-
依托单位:
基于NASBA-侧向层析联用的HIV-1 RNA检测方法构建及其扩增-识别耦合机制研究
-
批准号:JCZRLH202601701
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
基于病人旅程地图的HIV/AIDS患者双轨调适策略的混合性研究
-
批准号:2026JJ81431
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:夏友
-
依托单位:
HERC2-Sp1轴调控HIV-1潜伏的机制及干预研究
-
批准号:82660463
-
项目类别:地区科学基金项目
-
资助金额:32.00万元
-
批准年份:2026
-
负责人:周晨亮
-
依托单位:
HIV-1低病毒血症患者储存库活性与耐药突变评价体系的临床应用研究
-
批准号:2026JJ30181
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:陈钟
-
依托单位:
HIV介导树突状细胞线粒体损伤通过PD-L1通路促进潜伏结核激活的机制研究
-
批准号:2026JJ82503
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:李榜龙
-
依托单位: